biologic

PENBRAYA

Meningococcal Groups A, B, C, W, and Y Vaccine

Loss of exclusivity—loss of exclusivity

CompanyPfizer Ireland Pharmaceuticals Unlimited Company

Drug detail

Brand name	PENBRAYA
Active ingredient	Meningococcal Groups A, B, C, W, and Y Vaccine
Strength	5UG
Dosage form	Injection
Route	Intramuscular
Modality	Biologic
Marketing status	Rx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.